Browse Studies — Arctuva

Phase 2

A Phase II Trial of T Cell Receptor Gene Therapy Targeting Human Papillomavirus ( HPV) 16 E7 for HPV-Associated Cancers

This is a phase II clinical trial to assess the clinical activity of immunotherapy with E7 TCR-T cells for metastatic HPV-associated cancers. HPV-associated ca…

Cervical CancerThroat CancerOropharynx Cancer+18 more

Estimated

~$10 – $7,500

Christian HinrichsNCT05686226

Circulating HPV DNA in Cancers of the Anus and Uterine Cervix Treated With Definitive Radiation Therapy

This is a research study for individuals who have cancer associated with human papillomavirus (HPV) and are being treated with radiation as part of standard ca…

Cervical CancerAnal CancerHPV-Related Anal Squamous Cell Carcinoma+3 more

Estimated

~$10 – $750

University of ChicagoNCT04857528

Phase 1

An Open-Label Phase 1/2a Clinical Trial to Evaluate the Safety, Immunogenicity, and Preliminary Efficacy of a Lentiviral Vector-Based Therapeutic Vaccine Against Human Papilloma Virus (Lenti-HPV-07) in Participants With HPV-Associated Oropharyngeal Squamous Cell Cancer or Cervical Cancer

The goal of this clinical trial is to learn about the safety and efficacy of a potential new treatment called Lenti-HPV-07 in patients with a cancer induced by…

HPV-Related Cervical CarcinomaHPV Positive Oropharyngeal Squamous Cell Carcinoma

Estimated

~$10 – $8,750

Theravectys S.A.NCT06319963